Stay updated with breaking news from Senza System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic...
November 1, 2021: Edina, Minn. (PRWEB) November 03, 2021 -- Twin Cities Pain Clinic is now proudly offering spinal cord stimulation (SCS) therapy for the
/PRNewswire/ -- NeoSpine is now offering spinal cord stimulation (SCS) procedure(s) for the treatment of painful diabetic neuropathy (PDN). The technology is a...
The key companies are investing more towards R&D to develop innovative products since there is a shift from pharmaceutical treatment to medical devices in patients expected to drive the Pain
Here's Why You Should Hold on to Nevro (NVRO) Stock Now Zacks.com 5/13/2021 Nevro Corp. NVRO is well poised for growth on the back of its flagship platform Senza and solid international prospects. However, intense competition continues to mar prospects. Popular Searches The stock has gained 22.6% compared with the industry’s growth of 18.2% in a year’s time. Nevro with a market capitalization of $5.25 billion is a medical device company that engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. Its trailing four...